Smartkarma Originals
Asian Healthcare - Coming of Age
This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...
878 Views
Carelabs IPO Preview (Part 2) - Appealing Valuations
We would take the Carelabs IPO deal, even at the high end of the IPO price range (18,000 won). Our one-year fair value of the company is 27,700...
232 Views
Carelabs IPO Preview (Part 1) - Leading Provider of Healthcare and Cosmetics Surgery O2O Platforms
Established in 2012, Carelabs Co Ltd (263700 KS) operates leading healthcare, beauty care, and cosmetics surgery O2O (online-to-offline) platforms...
348 Views
StubWorld - Set-Up & Unwind Extremes: China Everbright; Green Cross
This week: China Everbright Ltd (165 HK) is around the "cheapest" inside a year, with various opportunities to monetise assets expected in 2018;...
297 Views
Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle
As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...
2.2k Views